189
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

, , , , , , , , & show all
Pages 1545-1551 | Received 04 Mar 2004, Accepted 07 Mar 2004, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Craig W. Freyer, Alison Carulli, Alex Ganetsky, Mitchell E. Hughes, Tracy M. Krause, Colleen Timlin, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, Alison W. Loren, James K. Mangan, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Keith Pratz, David L. Porter & Selina M. Luger. (2020) Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & Lymphoma 61:9, pages 2200-2207.
Read now
Thomas Sau-Yan Chan, Yu Yan Hwang & Eric Tse. (2020) Risk assessment of venous thromboembolism in hematological cancer patients: a review. Expert Review of Hematology 13:5, pages 471-480.
Read now
Jason Chen, Dat Ngo, Ibrahim Aldoss, Sepideh Shayani, Ni-Chun Tsai & Vinod Pullarkat. (2019) Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia. Leukemia & Lymphoma 60:5, pages 1187-1192.
Read now
Jamie Koprivnikar, James McCloskey & Stefan Faderl. (2017) Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia. OncoTargets and Therapy 10, pages 1413-1422.
Read now
Jason N. Barreto, Kristen B. McCullough, Candy S. Peskey, Ross A. Dierkhising, Kristin C. Mara, Michelle A. Elliott, Dennis A. Gastineau, Aref Al-Kali, Naseema Gangat, Louis Letendre, William J. Hogan, Mark R. Litzow & Mrinal M. Patnaik. (2017) Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy. Leukemia & Lymphoma 58:11, pages 2588-2597.
Read now
Katrina Farrell, Andrew Fyfe, Jonathan Allan, R. Campbell Tait & Mike Leach. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia & Lymphoma 57:11, pages 2568-2574.
Read now
Wendy Stock, Dan Douer, Daniel J. DeAngelo, Martha Arellano, Anjali Advani, Lloyd Damon, Tibor Kovacsovics, Mark Litzow, Michael Rytting, Gautam Borthakur & Archie Bleyer. (2011) Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leukemia & Lymphoma 52:12, pages 2237-2253.
Read now
Ted Wun & Richard H. White. (2009) Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors. Cancer Investigation 27:sup1, pages 63-74.
Read now

Articles from other publishers (42)

Wojciech Lizurej, Łukasz Mazurkiewicz, Michał Kowalski, Sylwia Szydłowska, Michał Wyrzykowski & Krzysztof Lewandowski. (2023) Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report. Thrombosis Journal 21:1.
Crossref
Nidhi Dhariwal, Venkata Rama Mohan Gollamudi, K. P. Sangeetha, Badira Cheriyalinkal Parambil, Nirmalya Roy Moulik, Chetan Dhamne, Maya Prasad, Tushar Vora, Girish Chinnaswamy, Seema Kembhavi, Papagudi G. Subramanian, Sumeet Gujral, S. D. Banavali & Gaurav Narula. (2022) Pediatric cancer‐associated thrombosis: Analysis from a tertiary care cancer center in India. Pediatric Blood & Cancer 70:2.
Crossref
Rajashekar Sindhu & Haravey K. Manonmani. (2022) L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review. Anti-Cancer Agents in Medicinal Chemistry 22:13, pages 2393-2410.
Crossref
Sandra Lee, Anika Shenoy, Daniel Shi, Mootaz Husien, Pablo E. Serrano & Sameer Parpia. (2021) Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review. TH Open 05:03, pages e461-e469.
Crossref
Sarah M. Kashanian, Noa G. Holtzman, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Madhurima Koka, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Jummai Apata, Farin Kamangar & Ashkan Emadi. (2021) Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemotherapy and Pharmacology 87:6, pages 817-826.
Crossref
Ruiqi Chen, Xing Liu, Arjun D. Law, Solaf Kanfar, Dawn Maze, Steven M. Chan, Vikas Gupta, Karen W. Yee, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Caroline J. McNamara, Tracy Murphy, Anna Xu, Umberto Falcone, Jack Seki & Hassan Sibai. (2020) Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen. Current Oncology 28:1, pages 128-137.
Crossref
Cecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, Wendy Stock, Nina Toft, Ove Juul Nielsen, Thomas Leth Frandsen, Ruta Tuckuviene & Kjeld Schmiegelow. (2020) Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Gemlyn George, Alexandra Rezazadeh, Felicia Zook, Nicole Pearl, Cole McCoy, Karen Carlson, Lyndsey Runaas, Sameem Abedin, Guru Subramanian Guru Murthy, Laura C. Michaelis, Ehab Atallah & Lisa Baumann-Kreuziger. (2020) Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study. Leukemia Research 94, pages 106368.
Crossref
J. Fulcher & M. Carrier. (2020) Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?. Thrombosis Research 188, pages 100-102.
Crossref
Jeffrey I. Zwicker, Tzu‐Fei Wang, Daniel J. DeAngelo, Mandy N. Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters & Marc Carrier. (2020) The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis 18:2, pages 278-284.
Crossref
Najeebah A Bade, Crystal Lu, Ciera L Patzke, Maria R Baer, Vu H Duong, Jennie Y Law, Seung T Lee, Edward A Sausville, Ann B Zimrin, Alison P Duffy, Justin Lawson & Ashkan Emadi. (2019) Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice 26:1, pages 74-92.
Crossref
Patrick W. Burke, Dieter Hoelzer, Jae H. Park, Kjeld Schmiegelow & Dan Douer. (2020) Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion. ESMO Open 5:5, pages e000858.
Crossref
Tina Rizack & Jorge J. Castillo. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 882 893.e3 .
Shlomit Yust-Katz, Simon Khagi & Mark R. Gilbert. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 688 706.e7 .
Cecilie Utke Rank, Nina ToftRuta TuckuvieneKathrine GrellOve Juul NielsenThomas Leth Frandsen, Hanne Vibeke Hansen MarquartBirgitte Klug AlbertsenUlf TedgårdHelene HallböökEllen RuudKirsten Brunsvig JarvisPetter Quist-PaulsenPasi HuttunenUlla Wartiovaara-KauttoÓlafur Gísli JónssonSonata Saulyte TrakymieneLaimonas GriškevičiusKadri SaksMari Punab & Kjeld Schmiegelow. (2018) Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood 131:22, pages 2475-2484.
Crossref
Manal M. Ismail & Gehan M. Hamed. (2017) Activity levels of natural anticoagulant proteins in childhood acute lymphoblastic leukemia. Blood Coagulation & Fibrinolysis 28:1, pages 1-7.
Crossref
D. Eden, R. Hipkins & C. A. Bradbury. (2016) Cerebral Thrombotic Complications Related to l -Asparaginase Treatment for Acute Lymphoblastic Leukemia . Clinical and Applied Thrombosis/Hemostasis 22:6, pages 589-593.
Crossref
Mandy N Lauw, Lowiek M Hubers, Cornelia H van Ommen, Barbara A Hutten, Bart J Biemond & Saskia Middeldorp. (2016) Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemia. Cochrane Database of Systematic Reviews.
Crossref
Jason N. Barreto & Mrinal M. Patnaik. 2016. Nonmalignant Hematology. Nonmalignant Hematology 369 378 .
Marie‐Anne Couturier, Françoise Huguet, Patrice Chevallier, Felipe Suarez, Xavier Thomas, Martine Escoffre‐Barbe, Victoria Cacheux, Jean‐Michel Pignon, Caroline Bonmati, Laurence Sanhes, Pierre Bories, Etienne Daguindau, Véronique Dorvaux, Oumedaly Reman, Jamile Frayfer, Corentin Orvain, Véronique Lhéritier, Norbert Ifrah, Hervé Dombret, Mathilde Hunault‐Berger & Aline Tanguy‐Schmidt. (2015) Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l ‐asparaginase: The GRAALL experience . American Journal of Hematology 90:11, pages 986-991.
Crossref
Valerio De Stefano, Tommaso Za, Angela Ciminello, Silvia Betti & Elena Rossi. (2017) Haemostatic alterations induced by treatment with asparaginases and clinical consequences. Thrombosis and Haemostasis 113:02, pages 247-261.
Crossref
Tanya M. Petterson, Randolph S. Marks, Aneel A. Ashrani, Kent R. Bailey & John A. Heit. (2015) Risk of site-specific cancer in incident venous thromboembolism: A population-based study. Thrombosis Research 135:3, pages 472-478.
Crossref
Khanh Vu, Nhiem V. Luong, Julie Hubbard, Ali Zalpour, Stefan Faderl, Deborah A. Thomas, Daisy Yang, Hagop Kantarjian & Michael H. Kroll. (2014) A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center . Cancer Medicine 4:1, pages 27-35.
Crossref
Alia ZaidiLiza-Marie JohnsonChristopher L. ChurchWendy C. Gomez-GarciaMarcela I. PopescuJudith F. MargolinRaul C. Ribeiro. (2014) Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients: Two Illustrative Cases and Review of the Literature. Journal of Adolescent and Young Adult Oncology 3:4, pages 160-175.
Crossref
Jorge J. Castillo & Tina Rizack. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 914 925.e3 .
Shlomit Yust-Katz & Mark R. Gilbert. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 822 844.e6 .
E Truelove, A K Fielding & B J Hunt. (2012) The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia. Leukemia 27:3, pages 553-559.
Crossref
Mandy N. Lauw, Bronno van der Holt, Saskia Middeldorp, Joost C. M. Meijers, Jan J. Cornelissen, Mariateresa Bajetta & Bart J. Biemond. (2017) Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation. Thrombosis and Haemostasis 109:04, pages 633-642.
Crossref
Mandy N Lauw, Lowiek M Hubers, Cornelia H van Ommen, Barbara A Hutten, Bart J Biemond & Saskia Middeldorp. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
M. Essig, J. Dinkel & C. Zamecnik. (2012) Visualisierung von Strahlenfolgen am ZentralnervensystemVisualization of radiation effects on the central nervous system. Der Radiologe 52:3, pages 229-234.
Crossref
Rachael F. Grace, Suzanne E. Dahlberg, Donna Neuberg, Stephen E. Sallan, Jean M. Connors, Ellis J. Neufeld, Daniel J. DeAngelo & Lewis B. Silverman. (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. British Journal of Haematology 152:4, pages 452-459.
Crossref
X. Thomas, G. Cannas, Y. Chelghoum & A. Gougounon. (2010) Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte. Bulletin du Cancer 97:9, pages 1105-1117.
Crossref
Sunanda Sadanandan, Timothy Hurley, Carolyn Muller, Claire Verschraegen, Marianne Berwick, Charles L. Wiggins & Kimberly K. Leslie. 2010. de Swiet's Medical Disorders in Obstetric Practice. de Swiet's Medical Disorders in Obstetric Practice 553 582 .
Moya S. Cunningham, Roger J.S. Preston & James S. O’Donnell. (2009) Does antithrombotic therapy improve survival in cancer patients?. Blood Reviews 23:3, pages 129-135.
Crossref
Ted Wun & Richard H. White. (2009) Epidemiology of cancer-related venous thromboembolism. Best Practice & Research Clinical Haematology 22:1, pages 9-23.
Crossref
Jeanette H. Payne & Ajay J. Vora. (2007) Thrombosis and acute lymphoblastic leukaemia. British Journal of Haematology 138:4, pages 430-445.
Crossref
Umesh K. Narta, Shamsher S. Kanwar & Wamik Azmi. (2007) Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia. Critical Reviews in Oncology/Hematology 61:3, pages 208-221.
Crossref
Vanesa CarusoLicia IacovielloAugusto Di CastelnuovoSergio StortiGuglielmo MarianiGiovanni de GaetanoMaria Benedetta Donati. (2006) Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 108:7, pages 2216-2222.
Crossref
Matthew Adess, Robert Eisner, Sucha Nand, John Godwin, Harry L. MessmoreJrJr & William H. Wehrmacher. (2016) Thromboembolism in Cancer Patients: Pathogenesis and Treatment. Clinical and Applied Thrombosis/Hemostasis 12:3, pages 254-266.
Crossref
M.S. Cunningham, B. White & J. O'Donnell. (2006) Prevention and Management of Venous Thromboembolism in People with Cancer: A Review of the Evidence. Clinical Oncology 18:2, pages 145-151.
Crossref
Timothy J. Hurley, James V. McKinnell & Mehraboon S. Irani. (2005) Hematologic Malignancies in Pregnancy. Obstetrics and Gynecology Clinics of North America 32:4, pages 595-614.
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.